While the exact regulation and function of CCL22 in tumor cells needs to be further elucidated, our data suggest that CCL22 levels in stroma and myometrium might be an important parameter for the intratumoral accumulation of immunosuppressive Treg. This evidence concerns the gene CCL22 and neoplasm.